MaxCyte Inc (MXCT.L)

Name: MaxCyte Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Devices

Latest reporting period: 2025-03-31

Latest Quarter

2025-03-31

Revenue

$10.4M

Net Income

-$10.3M

Operating Margin

-108.1%

Free Cash Flow

-$29.3M

Debt / Assets

13.9%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for MaxCyte Inc (MXCT.L).
Income Statement (Quarterly)	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Revenue	10,390,000	8,693,000	8,164,000	10,429,000
Cost of Revenue	1,497,000	2,281,000	1,928,000	2,522,000
Gross Profit	8,893,000	6,412,000	6,236,000	7,907,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	14,224,000	13,679,000	13,952,000	14,229,000
Operating Expenses	20,127,000	19,313,000	20,289,000	19,848,000
Operating Income	-11,234,000	-12,901,000	-14,053,000	-11,941,000
Interest Expense	0	0	0	0
Income Before Tax	-10,261,000	-10,597,000	-11,557,000	-9,375,000
Income Tax Expense	0	0	0	0
Net Income	-10,261,000	-10,597,000	-11,557,000	-9,375,000
Per Share
EPS	-0.10	-0.10	-0.11	-0.09
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for MaxCyte Inc (MXCT.L).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	33,026,000	38,627,000	41,288,000	44,261,500	33,894,100
Cost of Revenue	6,222,000	7,100,000	4,742,000	5,098,400	3,647,400
Gross Profit	26,804,000	31,527,000	36,546,000	39,163,100	30,246,700
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	47,040,000	56,354,000	57,043,000	44,481,600	31,678,900
Operating Expenses	72,479,000	82,724,000	84,845,000	66,523,600	48,435,300
Operating Income	-43,546,000	-51,197,000	-48,299,000	-27,360,500	-18,188,600
Interest Expense	0	0	0	126,900	1,044,400
Income Before Tax	-44,630,000	-41,055,000	-37,923,000	-23,570,800	-19,082,200
Income Tax Expense	0	0	0	-3,789,700	0
Net Income	-44,630,000	-41,055,000	-37,923,000	-19,781,100	-19,082,200
Per Share
EPS	-0.42	-0.39	-0.37	-0.19	-0.21
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for MaxCyte Inc (MXCT.L).
Balance Sheet (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	27,884,000	46,506,000	11,064,700	47,782,400
Short Term Investments	126,598,000	121,782,000	216,274,900	207,261,400
Net Receivables	4,682,000	5,778,000	13,567,000	6,877,000
Inventory	8,914,000	12,229,000	8,580,800	5,204,600
Total Current Assets	171,684,000	190,194,000	252,266,200	270,432,800
Property Plant Equipment	30,473,000	34,754,000	33,578,200	13,370,500
Goodwill and Intangibles	0	0	0	0
Total Assets	239,470,000	268,274,000	286,653,400	284,120,000
Liabilities
Account Payables	1,358,000	743,000	531,800	1,820,300
Short Term Debt	864,000	774,000	156,800	527,200
Total Current Liabilities	15,775,000	17,855,000	15,426,500	15,617,800
Long Term Debt	17,170,000	17,969,000	15,938,100	5,154,900
Total Liabilities	33,219,000	36,107,000	32,686,200	21,222,900
Shareholders Equity
Retained Earnings	-216,853,000	-175,798,000	-137,875,300	-114,304,500
Total Shareholders Equity	206,251,000	232,167,000	253,967,200	262,897,100

Balance sheet annual history for MaxCyte Inc (MXCT.L).
Balance Sheet (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets
Cash and Cash Equivalents	27,884,000	46,506,000	11,064,700	47,782,400	18,755,200
Short Term Investments	126,598,000	121,782,000	216,274,900	207,261,400	16,007,500
Net Receivables	4,682,000	5,778,000	13,567,000	6,877,000	0
Inventory	8,914,000	12,229,000	8,580,800	5,204,600	4,315,800
Total Current Assets	171,684,000	190,194,000	252,266,200	270,432,800	45,253,400
Property Plant Equipment	30,473,000	34,754,000	33,578,200	13,370,500	6,492,800
Goodwill and Intangibles	0	0	0	0	0
Total Assets	239,470,000	268,274,000	286,653,400	284,120,000	51,780,100
Liabilities
Account Payables	1,358,000	743,000	531,800	1,820,300	890,200
Short Term Debt	864,000	774,000	156,800	527,200	0
Total Current Liabilities	15,775,000	17,855,000	15,426,500	15,617,800	11,614,300
Long Term Debt	17,170,000	17,969,000	15,938,100	5,154,900	4,917,000
Total Liabilities	33,219,000	36,107,000	32,686,200	21,222,900	18,554,700
Shareholders Equity
Retained Earnings	-216,853,000	-175,798,000	-137,875,300	-114,304,500	-95,222,300
Total Shareholders Equity	206,251,000	232,167,000	253,967,200	262,897,100	33,225,400

Cash flow quarterly history for MaxCyte Inc (MXCT.L).
Cash Flow Statement (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-41,055,000	-37,923,000	-23,570,800	-19,082,200
Depreciation & Amortization	4,790,000	4,171,000	2,697,900	1,423,900
Stock Based Compensation	13,083,000	13,979,000	11,752,400	7,958,800
Change in Working Capital	-751,000	3,820,000	-3,210,900	-1,644,700
Operating Cash Flow	-27,610,000	-21,686,000	-14,782,900	-10,679,600
Investing Activities
Capital Expenditure	-1,651,000	-3,700,000	-18,477,200	-3,834,200
Investments	-1,651,000	-3,700,000	-18,477,200	-3,834,200
Investing Cash Flow	6,932,000	54,984,000	-24,823,300	-195,013,200
Financing Activities
Debt Repayment	0	0	0	-4,988,500
Common Stock Issued/Repurchased	459,000	269,000	0	236,077,300
Dividends Paid	0	0	0	0
Financing Cash Flow	2,056,000	2,143,000	2,888,500	234,720,000
Summary
Free Cash Flow	-29,261,000	-25,386,000	-33,260,100	-14,513,800
Net Change in Cash	-18,622,000	35,441,000	-36,717,700	29,027,200

Cash flow annual history for MaxCyte Inc (MXCT.L).
Cash Flow Statement (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Operating Activities
Net Income	-41,055,000	-37,923,000	-23,570,800	-19,082,200	-11,816,400
Depreciation & Amortization	4,790,000	4,171,000	2,697,900	1,423,900	1,047,700
Stock Based Compensation	13,083,000	13,979,000	11,752,400	7,958,800	2,471,800
Change in Working Capital	-751,000	3,820,000	-3,210,900	-1,644,700	-858,200
Operating Cash Flow	-27,610,000	-21,686,000	-14,782,900	-10,679,600	-8,782,100
Investing Activities
Capital Expenditure	-1,651,000	-3,700,000	-18,477,200	-3,834,200	-2,072,100
Investments	-1,651,000	-3,700,000	-18,477,200	-3,834,200	-2,072,100
Investing Cash Flow	6,932,000	54,984,000	-24,823,300	-195,013,200	-16,578,000
Financing Activities
Debt Repayment	0	0	0	-4,988,500	-1,440,000
Common Stock Issued/Repurchased	459,000	269,000	0	236,077,300	28,968,200
Dividends Paid	0	0	0	0	0
Financing Cash Flow	2,056,000	2,143,000	2,888,500	234,720,000	28,904,500
Summary
Free Cash Flow	-29,261,000	-25,386,000	-33,260,100	-14,513,800	-10,854,200
Net Change in Cash	-18,622,000	35,441,000	-36,717,700	29,027,200	3,544,400